These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neisseria gonorrhoeae isolates from four centres in Papua New Guinea remain susceptible to amoxycillin-clavulanate therapy. Toliman PJ, Lupiwa T, Law GJ, Reeder JC, Siba PM. P N G Med J; 2010; 53(1-2):15-20. PubMed ID: 22768475 [Abstract] [Full Text] [Related]
9. Cefotaxime in the treatment of gonorrhoea caused by penicillinase producing N. gonorrhoeae (PPNG) and non penicillinase producing N. gonorrhoeae (Non PPNG). Panikabutra K, Ariyarit C, Chitwarakorn A, Warnisorn T. J Med Assoc Thai; 1982 May; 65(5):271-6. PubMed ID: 6288828 [No Abstract] [Full Text] [Related]
13. Management of penicillinase-producing Neisseria gonorrhoeae (PPNG)--audits in 1990 and 1992. Sherrard J, Barlow D. Int J STD AIDS; 1993 Jun; 4(3):182. PubMed ID: 8324051 [No Abstract] [Full Text] [Related]
14. Spectinomycin as primary treatment of gonorrhea in areas of high prevalence of penicillinase-producing Neisseria gonorrhoeae. Berg SW, Harrison WO. Sex Transm Dis; 1981 Jun; 8(1):38-9. PubMed ID: 6452709 [No Abstract] [Full Text] [Related]